Gonadotropin-releasing hormone-dependent

Christian CA, Mobley JL, Moenter SM. Diurnal and estradiol-dependent changes in gonadotropin-releasing hormone neuron firing activity. Proc Natl Acad Sci USA. 2005 102 15682-15687. 

Jinshu, X., Jingjing, L., Duan, P., et al. (2005) A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant. Vaccine 23(40), 4834 1843. 

ACTH, adrenocorticotropic hormone FSH, follicle stimulating hormone GnRH, gonadotropin releasing hormone LH, luteinizing hormone TSH, thyroid stimulating hormone Note Some of above clinical assessment tools are age and/or sex dependent. ... 

Fig. 15 Capillary electrophoresis-mass spectrometry profile of two peptides preconcentrated on-line prior to separation. (A) Electropherogram of neurotensin (1) and angiotensin (2), concentrated and purified by C-18 immobilized to porous beads and monitored at 195 nm after separation by CE. (B) Total ion-current electropherogram of the separated peptides. The experimental conditions were similar to those described in Ref. 120 for gonadotropin-releasing hormone. The limits of detection for the peptides were approximately 1 to 5 ng/mL, depending primarily on the quality of the analyte concentrator-microreactor.

ENDOCRINE SYSTEM A number of endocrine tissues respond to PGs. In a number of species, the systemic administration of PGE increases circulating concentrations of adrenocorticotropic hormone (ACTH), growth hormone, prolactin, and gonadotropins. Other effects include stimulation of steroid production by the adrenals, stimulation of insulin release, and thyrotropinlike effects on the thyroid. The critical role of PGF in parturition relies on its ability to induce an oxytocin-dependent decline in progesterone levels. PGE works as part of a positive-feedback loop to induce oocyte maturation required for fertihzation during and after ovulation. 

---